LarryD.StonesiferMD

Clinical Trials

• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication Start of enrollment: 2010 Oct 01

  Completed

  Phase 3

• CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Start of enrollment: 2010 Nov 11

  Completed

  Phase 3

• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors Start of enrollment: 2014 Jan 24

  Completed

  Phase 4

• Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2) Start of enrollment: 2015 Jun 30

  Completed

  Phase 3

• Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01

  Completed

  Not Applicable

• An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2015 Oct 20

  Completed

  Phase 3

• Mylan Insulin Aspart Study Start of enrollment: 2018 Nov 07

  Completed

  Phase 3

• Join now to see all